Latest news with #cataractSurgery
Yahoo
5 days ago
- Business
- Yahoo
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference in Boston. RxSight's management is scheduled to present on Thursday, September 4, 2025, at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time. A live and archived webcast of the presentation will be available at: About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at Company Contact:Shelley B. ThunenChief Financial Officersthunen@ Investor Relations Contact:Oliver MoravcevicVP, Investor Relationsomoravcevic@ in to access your portfolio
Yahoo
06-08-2025
- Health
- Yahoo
OCLI Vision Welcomes Ophthalmologist Dr. Maryam Ige to Queens Locations at the Fishman Center for Total Eye Care
GARDEN CITY, N.Y., Aug. 6, 2025 /PRNewswire/ -- OCLI Vision, a Spectrum Vision Partners managed practice, is pleased to announce the addition of Dr. Maryam Ige, a highly accomplished ophthalmologist specializing in comprehensive eye care, cataract surgery, and glaucoma, to its expanding team. Dr. Ige began seeing patients on July 23, 2025, and is now accepting new patients at the Fishman Center for Total Eye Care | OCLI Vision locations in Rego Park and Jackson Heights, Queens. Dr. Ige brings a wealth of clinical and academic experience to OCLI Vision. She recently completed her ophthalmology residency at Northwestern University, where she served as Chief Resident. Throughout her training, Dr. Ige has been deeply engaged in diversity, equity, and inclusion (DEI) initiatives and has contributed significant research focused on improving diagnostics and treatment options for diabetic eye disease, macular degeneration, and glaucoma. Her work has been featured in several top-tier ophthalmology journals. A graduate of Yale School of Medicine, Dr. Ige earned her medical degree after completing her undergraduate studies at Stony Brook University, where she graduated summa cum laude with a Bachelor of Engineering in Biomedical Engineering. Her numerous accolades include the Northwestern Department of Ophthalmology Research Award and the Dr. John E. Franklin Commitment to Diversity Award, underscoring her dedication to both clinical excellence and equitable patient care. "I'm honored to join the exceptional team at the Fishman Center for Total Eye Care," said Dr. Ige. "Working alongside renowned physicians like Dr. Allen J. Fishman and Dr. Ghulam Dastgir is a privilege. I'm excited to bring my clinical experience and passion for equitable care to patients in the Queens community." Now Accepting New Patients Dr. Ige participates in most major insurance plans and is now seeing patients at the following locations: Fishman Center for Total Eye Care | OCLI Vision – Rego Park 92-29 Queens Blvd, STE 2-I, Rego Park, NY 11374 Phone: (718) 261-7007 Fishman Center for Total Eye Care | OCLI Vision – Jackson Heights 93-20A Roosevelt Ave, Jackson Heights, NY 11373 Phone: (718) 261-7007 To schedule an appointment or learn more, please visit About OCLI Vision Founded in 1997, OCLI Vision is one of the premier ophthalmology practices in the United States, offering cutting-edge eye care across New York, New Jersey, Connecticut, Pennsylvania, and West Virginia. The group is composed of highly skilled ophthalmologists and optometrists across every major eye care subspecialty—including cataracts, glaucoma, cornea, retina, oculoplastics, and refractive surgery. Learn more at About Spectrum Vision Partners Spectrum Vision Partners (SVP) is a leading management services organization in the ophthalmology space, supporting a network of over 120 doctors across 60+ clinic locations and five ambulatory surgery centers. With a team of nearly 1,300 professionals, SVP provides comprehensive business support services—from marketing and finance to IT and recruitment. For more information, visit View original content to download multimedia: SOURCE OCLI Vision Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-07-2025
- Business
- Yahoo
This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'
ForSight Robotics, an Israeli startup aiming to automate cataract and eye surgery, announced Tuesday that it raised $125 million to expand its precision robotics platform, Oryom. The round was led by Eclipse Ventures, with participation from surgical robotics legend Fred Moll, co-founder of Intuitive Surgical, and Moshe Shoham, a Technion professor and pioneer behind multiple robotics companies including Mazor, which was acquired by Medtronic for $1.6 billion, Forbes reports. Don't Miss: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Forbes says that more than 4 million cataract surgeries are performed each year in the U.S. alone. Yet, according to a World Health Organization report, over 1 billion people globally suffer from preventable vision loss. As the population ages and the number of ophthalmologists declines, a gap is forming that traditional medical systems can't fill. "There is no human way to close the gap as we see it," Dr. Joseph Nathan, ForSight co-founder and chief medical officer, told Forbes. "Robotics will have to take over." Cataract surgery is a highly precise procedure that involves operating within extremely small spaces, requiring steady hands and dexterous control, according to Forbes. ForSight says its Oryom platform is designed specifically to handle the complexity and consistency of ophthalmic procedures using AI-based algorithms, computer vision, and micromechanics to enhance surgical precision and reduce the physical strain on surgeons. Over the past year, more than two dozen ophthalmic surgeons have used the platform to successfully perform hundreds of procedures on animal eye models as part of the system's development and testing phase. Forbes reports that ForSight has specifically tested its robotic system on porcine eyes due to their close anatomical similarity to human eyes, a common method used in ophthalmic surgical training. Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — The company says it has yet to perform surgery on a human patient, but expects to begin clinical trials by the end of the year. Early conversations with the Food and Drug Administration are already underway, and the new funding will carry the company through its regulatory process. ForSight was born out of Israel's Technion Institute, where Shoham, Nathan, and co-founder Daniel Glozman combined decades of expertise in medical engineering, research and development, and commercialization. Shoham's previous students have gone on to lead Medtronic's robotics division and build multi-billion-dollar exits. Moll and Shoham, often called "the godfathers of surgical robotics," now advise the company strategically, Forbes reports. "There is only one procedure that is done more than cataract surgery and that is blood drawing," Moll told Forbes. "As far as real surgical technique [that could be helped by robotics], cataract surgery is at the top of the list." With its third-generation prototype complete, ForSight is already preparing to expand its platform's capabilities beyond cataracts. Forbes says that future use cases include retinal procedures, glaucoma treatments, and complex eye surgeries that currently only a handful of surgeons in the world are qualified to Oryom system provides a potential answer to a looming global health crisis. According to the company, there are only 31.7 ophthalmologists and 14.1 cataract surgeons per million people globally, highlighting a significant gap between demand and surgical capacity. This surgeon shortage, combined with rising rates of preventable blindness, suggests that millions may not receive timely care. A 2020 study published in the British Journal of Ophthalmology, further confirms that lower-income countries average just 3.7 ophthalmologists per million people, compared to 76.2 in high-income nations, underscoring the disparity in access to eye care worldwide. By automating precision eye surgery, ForSight is betting on a future where access to vision care is no longer limited by geography or availability of human doctors. If successful, the company may become the Intuitive Surgical of ophthalmology. Read Next: Here's what Americans think you need to be considered wealthy. Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report This article This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
CNA
28-05-2025
- Business
- CNA
AI platform Enigma slashes clinical audit time by 90%
Singapore is using artificial intelligence to tackle challenges of an ageing population and reduce stress on hospitals. At the Singapore National Eye Centre, AI platform Enigma helped to conduct clinical audits for cataract surgeries. It analysed more than one million data points over six months last year, cutting down processing time by 90%.
Jordan Times
08-05-2025
- Health
- Jordan Times
MAP Jordan, partners deliver vision care to over 2,000 patients since 2024
The Jordan Medical Aid for Palestinians, in partnership with Al Basar International Foundation and Al Khansa Hospital, concludes the fourth and fifth phases of its ongoing anti-blindness campaign (Photo courtesy of Jordan Medical Aid for Palestinians) AMMAN — The Jordan Medical Aid for Palestinians (MAP Jordan), in partnership with Al Basar International Foundation and Al Khansa Hospital, has concluded the fourth and fifth phases of its ongoing anti-blindness campaign, delivering 930 free cataract surgeries to patients living in refugee camps across the Kingdom. With this latest effort, the total number of surgeries performed since the campaign launched in January 2024 has reached 2,250. Earlier phases saw 399 surgeries in the first round, followed by 923 across the second and third, according to a MAP Jordan statement. In the fourth and fifth phases alone, over 8,000 individuals were screened. Alongside the surgeries, patients received free eye drops and prescription eyeglasses—part of a comprehensive initiative aimed at enhancing vision care and improving the quality of life for underserved communities. 'This initiative goes beyond numbers,' said Islam Mohamad, program supervisor at MAP Jordan. 'Each surgery tells a story of transformation, children seeing their parents clearly for the first time, young adults returning to work and education, and elderly individuals regaining their independence. It's about restoring dignity, hope, and a sense of purpose.' The success of the campaign reflects the deep partnership between MAP Jordan and its partners, as well as the support of donors and volunteers who continue to fuel the mission, according to the statement. Plans are already underway for future campaigns as part of the long-term vision to eliminate preventable blindness across Jordan's refugee populations, the statement said.
